Romark Revenue and Competitors
Estimated Revenue & Valuation
- Romark's estimated annual revenue is currently $19.1M per year.
- Romark received $1.9M in venture funding in July 2014.
- Romark's estimated revenue per employee is $201,000
- Romark's total funding is $67.7M.
Employee Data
- Romark has 95 Employees.
- Romark grew their employee count by -18% last year.
Romark's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP Managed Markets | Reveal Email/Phone |
2 | VP, Global Quality | Reveal Email/Phone |
3 | Head operations for moark global pharma | Reveal Email/Phone |
4 | Chief Medical & Science Officer | Reveal Email/Phone |
5 | EVP & Chief Operating Officer | Reveal Email/Phone |
6 | Director, Analysis and Planning | Reveal Email/Phone |
7 | Director Business Administration | Reveal Email/Phone |
8 | Director, Head Medical Science Liaisons,MSL-BC | Reveal Email/Phone |
9 | Analytical Development Laboratory Director | Reveal Email/Phone |
10 | Specialty Territory Manager | Reveal Email/Phone |
Romark Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $26.5M | 132 | N/A | N/A | N/A |
#2 | $10.1M | 50 | 14% | N/A | N/A |
#3 | $282.6M | 1406 | N/A | N/A | N/A |
#4 | $13.9M | 69 | 44% | N/A | N/A |
#5 | $11.3M | 56 | 4% | N/A | N/A |
#6 | $11.5M | 57 | -7% | N/A | N/A |
#7 | $211.7M | 1072 | 4% | N/A | N/A |
#8 | $24.1M | 120 | 5% | N/A | N/A |
#9 | $7.8M | 39 | -2% | N/A | N/A |
#10 | $12.9M | 64 | -2% | N/A | N/A |
What Is Romark?
Romark, L.C. is a pharmaceutical company committed to the discovery, development and commercialization of innovative small molecules for treating infectious diseases and cancers. Our people share a passion for scientific discovery and a desire to make a difference in the world's health. Throughout all phases of drug discovery and development, we are teamed in a quest to provide new treatments for diseases that impact the lives of people worldwide The Company uses a proprietary technology platform to discover small molecules targeting cell signaling pathways. This research has led to the discovery of a new class of drugs called the thiazolides. The first thiazolide, nitazoxanide, is already commercialized in the United States. Other new compounds and uses are being developed as part of several collaborative research programs.
keywords:N/A
$67.7M
Total Funding
95
Number of Employees
$19.1M
Revenue (est)
-18%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Romark News
Romark is next set to produce Marian at Sony Pictures alongside Amy Pascal and Donald De Line, as well as Matriarch at Paramount with Doug Wick.
That money should have been paid to 139 workers of Romark Laboratories, an average of $13,980.15 per employee. Labor said the Wage and Hour...
Employer: Romark Laboratories LC · Investigation sites: 3000 Bayport Drive, Tampa FL and · Investigation findings: · Back Wages Recovered: · Quote:...
Other Companies in Tampa
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $9.5M | 95 | 0% | N/A |
#2 | $25.7M | 95 | 10% | N/A |
#3 | $33.5M | 95 | 8% | N/A |
#4 | $13.8M | 95 | 27% | N/A |
#5 | $3.5M | 96 | 13% | $20M |
Romark Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2007-12-26 | $18.0M | Undisclosed | D.E. Shaw Group | Article |
| 2014-06-17 | $15.0M | Undisclosed | Article | |
| 2014-07-10 | $1.9M | Undisclosed | Article |